Go Pro

David Adlington Analyst Performance

Analyst at JPMorgan Chase & Co.

David Adlington is a stock analyst at JPMorgan Chase & Co. in the healthcare sector, covering 4 publicly traded companies. Over the past year, David Adlington has issued 3 stock ratings, including and hold recommendations. While full access to David Adlington's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Adlington's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
7 Last 5 Years
Buy Recommendations
0.00% 0 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy0.0%0 ratings
Hold100.0%7 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Hold recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
50.0% of companies on NYSE
2 companies
OTCMKTS
50.0% of companies on OTCMKTS
2 companies

David Adlington, an analyst at JPMorgan Chase & Co., currently covers 4 companies listed on NYSE and OTCMKTS, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Healthcare
4 companies
100.0%

David Adlington of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
HEALTHCARE EQUIPMENT & SUPPLIES
4 companies
100.0%

David Adlington's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Alcon stock logo
ALC
Alcon
8/12/2026Boost Price Target$72.22$78.40Neutral
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
8/6/2026Reiterated Rating$30.14Neutral
Alcon stock logo
ALC
Alcon
8/21/2025Reiterated Rating$81.04$77.53Neutral